(Q43948536)

English

Long-term effect of three different strategies for mass diethylcarbamazine administration in bancroftian filariasis: follow-up at 10 years after treatment

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Long-term effect of three different strategies for mass diethylcarbamazine administration in bancroftian filariasis: follow-up at 10 years after treatment (English)

1 reference

Europe PubMed Central

28 November 2017

0 references

diethylcarbamazine

1 reference

based on heuristic

inferred from title

Wuchereria bancrofti filariasis

1 reference

based on heuristic

inferred from title

author name string

Dan W Meyrowitsch

1

1 reference

Europe PubMed Central

28 November 2017

Paul E Simonsen

2

1 reference

Europe PubMed Central

28 November 2017

Stephen M Magesa

3

1 reference

Europe PubMed Central

28 November 2017

publication date

1 November 2004

1 reference

Europe PubMed Central

28 November 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

28 November 2017

98

1 reference

Europe PubMed Central

28 November 2017

627-634

1 reference

Europe PubMed Central

28 November 2017

11

1 reference

Europe PubMed Central

28 November 2017

Antigenemia at 10 years after diethylcarbamazine treatment of asymptomatic microfilaraemic individuals: marginal conversion to infection-free state

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

Genetic variation in immune function and susceptibility to human filariasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

Microfilaraemia, serum antibody and development of clinical disease in microfilaraemic subjects infected with Wuchereria bancrofti and treated with diethylcarbamazine citrate

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

A new tool to assess the adulticidal efficacy in vivo of antifilarial drugs for bancroftian filariasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

Bancroftian Filariasis: Long-Term Effects of Treatment with Diethylcarbamazine in a Haitian Population

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

Long-term effect of mass diethylcarbamazine chemotherapy on bancroftian filariasis, results at four years after start of treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

A 16-year follow-up study on bancroftian filariasis in three communities of north-eastern Tanzania.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis: comparative efficacy of standard treatment and two semi-annual single-dose treatments

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis through community participation: comparative efficacy of a low monthly dose and medicated salt.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

Mass DEC chemotherapy for control of bancroftian filariasis: comparative efficacy of four strategies two years after start of treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

Transmission intensity and the immunoepidemiology of bancroftian filariasis in East Africa.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

The global programme to eliminate lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

Bancroftian filariasis: a 13-year follow-up study of asymptomatic microfilariae carriers and endemic normals in Orissa, India

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

Bancroftian filariasis infection, disease, and specific antibody response patterns in a high and a low endemicity community in East Africa.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

Estimation of the fecund life span of Wuchereria bancrofti in an endemic area

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

Long-term persistence of cellular hyporesponsiveness to filarial antigens after clearance of microfilaremia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Bancroftian filariasis: analysis of infection and disease in five endemic communities of north-eastern Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.01.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.TRSTMH.2004.01.004

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43948536&oldid=2104583579"